Literature DB >> 30795972

Is Resolution the End of Inflammation?

Karen T Feehan1, Derek W Gilroy2.   

Abstract

Deciphering the origins of chronic inflammatory and autoimmune diseases remains elusive with reliance on therapies aimed at halting inflammation in its tracks. In recent years, an appreciation of targeting pathways by which inflammation is resolved has begun to rouse interest. Resolution of inflammation is driven by a complex set of mediators that regulate cellular events required to clear inflammatory cells from sites of infection or injury to restore tissue function. However, recent studies suggest that resolution is not the end of innate mediated immune responses to infection/injury. There is further immunological activity occurring after the resolution cascade is complete that alters the immune physiology of tissues, redefining what was once termed restorative homeostasis as adapted homeostasis.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  adapted homeostasis; autoimmunity; chronic inflammation; post-resolution; resolution

Year:  2019        PMID: 30795972     DOI: 10.1016/j.molmed.2019.01.006

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  41 in total

1.  Inflammatory Networks Linking Oral Microbiome with Systemic Health and Disease.

Authors:  S E Kleinstein; K E Nelson; M Freire
Journal:  J Dent Res       Date:  2020-05-27       Impact factor: 6.116

Review 2.  Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease.

Authors:  Ting Fu; Muthukumar Mohan; Eoin P Brennan; Owen L Woodman; Catherine Godson; Phillip Kantharidis; Rebecca H Ritchie; Cheng Xue Qin
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-17

Review 3.  NLRP3 Inflammasome: a Novel Insight into Heart Failure.

Authors:  Yunjiao Wang; Yanyang Li; Wanqin Zhang; Zhuo Yuan; Shichao Lv; Junping Zhang
Journal:  J Cardiovasc Transl Res       Date:  2022-06-13       Impact factor: 4.132

4.  Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer's Disease.

Authors:  Khanh V Do; Erik Hjorth; Ying Wang; Bokkyoo Jun; Marie-Audrey I Kautzmann; Makiko Ohshima; Maria Eriksdotter; Marianne Schultzberg; Nicolas G Bazan
Journal:  Cell Mol Neurobiol       Date:  2022-04-01       Impact factor: 5.046

5.  Dying cell-derived SAM switches off inflammation.

Authors:  Roel P H De Maeyer; Derek W Gilroy
Journal:  Nat Metab       Date:  2022-04

Review 6.  Effects of Anthraquinones on Immune Responses and Inflammatory Diseases.

Authors:  Dandan Xin; Huhu Li; Shiyue Zhou; Hao Zhong; Weiling Pu
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

Review 7.  Myeloid-derived suppressor cells (MDSC): When good intentions go awry.

Authors:  Maria Dulfary Sanchez-Pino; Matthew J Dean; Augusto C Ochoa
Journal:  Cell Immunol       Date:  2021-02-04       Impact factor: 4.868

8.  Inflammation and tumor progression: signaling pathways and targeted intervention.

Authors:  Huakan Zhao; Lei Wu; Guifang Yan; Yu Chen; Mingyue Zhou; Yongzhong Wu; Yongsheng Li
Journal:  Signal Transduct Target Ther       Date:  2021-07-12

9.  Human neutrophil membrane-derived nanovesicles as a drug delivery platform for improved therapy of infectious diseases.

Authors:  Jin Gao; Xinyue Dong; Yujie Su; Zhenjia Wang
Journal:  Acta Biomater       Date:  2021-01-18       Impact factor: 8.947

10.  Transcriptomics of type 2 diabetic and healthy human neutrophils.

Authors:  Sarah E Kleinstein; Jamison McCorrison; Alaa Ahmed; Hatice Hasturk; Thomas E Van Dyke; Marcelo Freire
Journal:  BMC Immunol       Date:  2021-06-16       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.